Oral Azithromycin Equivalent to Six Weeks Doxycycline for Meibomian Gland Dysfunction
FRIDAY, March 31, 2023 (HealthDay News) — Three weeks of oral azithromycin seems to be equivalent to six weeks of doxycycline for treatment of severe meibomian gland dysfunction (MGD), according to a study published online March 23 in JAMA Ophthalmol…
Learn MoreLos ciegos perciben mejor sus propios latidos cardiacos
MIÉRCOLES, 29 de marzo de 2023 (HealthDay News) — Las personas ciegas perciben mejor sus propios latidos cardiacos, según un nuevo estudio, que encontró que la ceguera parece mejorar la capacidad del individuo de percibir las señales del interior del…
Learn MoreBlind People Are Better at Sensing Their Heartbeats
WEDNESDAY, March 29, 2023 (HealthDay News) — People who are blind are better at sensing their own heartbeats, according to a new study that found blindness appears to heighten one’s ability to feel signals from the inner body.Researchers from Sweden …
Learn MoreKids With Autism Face Higher Odds of Vision Issues, But Many Don’t Get Screened
MONDAY, March 27, 2023 (HealthDay News) — Children with autism are less likely than their peers to receive important vision screening despite a high risk for serious eye disorders, researchers report.Only about 36% of children with autism spectrum di…
Learn MoreAumentan las muertes en el brote vinculado con unas gotas para los ojos retiradas
MIÉRCOLES, 22 de marzo de 2023 (HealthDay News) — Una bacteria resistente a los medicamentos vinculada con unas gotas para los ojos que se retiraron ya ha acabado con las vidas de tres personas.Los Centros para el Control y la Prevención de Enfermeda…
Learn MoreChildren With Autism Less Likely to Receive Vision Screening
WEDNESDAY, March 22, 2023 (HealthDay News) — Children with autism spectrum disorder (ASD) are less likely to receive vision screening at well-child visits at ages 3 and 5 years than those without ASD, according to a study published online March 21 in…
Learn MoreDeath Count Climbs in Outbreak Linked to Recalled Eye Drops
WEDNESDAY, March 22, 2023 (HealthDay News) — A drug-resistant bacteria linked to recalled eye drops has now killed three people.The U.S. Centers for Disease Control and Prevention reported Tuesday that infections with Pseudomonas aeruginosa had led t…
Learn MoreDeath Count Climbs in Outbreak Linked to Recalled Eyedrops
WEDNESDAY, March 22, 2023 (HealthDay News) – A drug-resistant bacteria linked to recalled eye drops has now killed three people.The U.S. Centers for Disease Control and Prevention reported Tuesday that infections with Pseudomonas aeruginosa had led to…
Learn MoreUnos científicos usan edición genética para revertir una importante causa de ceguera en estudio con ratones
VIERNES, 17 de marzo de 2023 (HealthDay News) — Un experimento de edición genética que restauró la visión de ratones podría algún día usarse para tratar a una importante causa de ceguera en los humanos.Unos científicos de China reportaron que usaron …
Learn MoreGlobal Prevalence of Diabetic Retinopathy ~7 Percent in Pediatric T2DM Patients
MONDAY, March 20, 2023 (HealthDay News) — The prevalence of diabetic retinopathy (DR) is 6.99 percent in pediatric type 2 diabetes (T2D) and increases with time since diagnosis, according to a meta-analysis published online March 17 in JAMA Network O…
Learn More